DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer

DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer

Background: Adjuvant chemotherapy (ACT) with 5-FU alone or 5-FU plus platinum after curative surgery improves the prognosis of pStage II-III gastric cancer (GC). However, only a subset of patients benefits from adjuvant platinum. To avoid the side effects of platinum, it is significant to accurately...

Full description

Bibliographic Details
Main Authors: Zhiyuan Fan, Beiqin Yu, Tao Pan, Fangyuan Li, Jianfang Li, Junyi Hou, Wentao Liu, Liping Su, Zhenggang Zhu, Chao Yan, Bingya Liu
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Translational Oncology
Subjects:
Gastric cancer
Adjuvant chemotherapy
Platinum
DKK1
Predictor
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322002364

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322002364

Similar Items